Skip to content
Home/Companies/Healthcare/Depth Charge Therapeutics

Depth Charge Therapeutics

Healthcare·Ireland·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Depth Charge Therapeutics?

Depth Charge Therapeutics is currently owned by AdBio Partners through AFB Fund II (2021 vintage), since 2021.

Hand-verified · updated 2026-05-24

AdBio Partners
Investor
AdBio Partners
AFB Fund II · 2021 · VC

Key facts

HQIreland
SectorHealthcare
StatusActive

More from AFB Fund II

Other portfolio companies in the same fund.

Orikine Bio
Active
HealthcareSpain· 2026
AndzonBio2
AndzonBio2
Active
HealthcareFrance· 2025
Cephagenix
Cephagenix
Active
HealthcareDenmark· 2025
EvlaBio
Active
HealthcareGermany· 2025
AndzonBio1
AndzonBio1
Active
HealthcareFrance· 2024
Anoat Therapeutics
Active
HealthcareFrance· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Depth Charge Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Depth Charge Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue